EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer

Stephanie Andrews, Steven P. Ludlow

Current Problems in Cancer: Case Reports · 2020

DOI: 10.1016/j.cpccr.2020.100014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Problems in Cancer: Case Reports, 2020. Verfasst von Stephanie Andrews und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has revolutionized medical oncology by providing durable responses in a number of malignancies. Programmed death-1 inhibitors are rapidly gaining popularity and increased use. They are also associated with a variety of adverse reactions. Although PD-1 inhibitors are generally tolerated relatively well and usually have milder side effects than chemotherapy, the risk remains for immune mediated adverse reactions. Caution should be exercised when re-challenging grade three or four adverse effects with the same agent or a different agent of the same class. The reemergence of a previous toxicity may occur or new toxicity. Immune related adverse events affect the nervous system and effects are generally mild however this case describes an exotic, fatal outcome in a patient with severe enteric neuropathy.

Zitieren

APA

Andrews, S., & Ludlow, S. P. (2020). Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer. Current Problems in Cancer: Case Reports. https://doi.org/10.1016/j.cpccr.2020.100014

Vancouver

Andrews S, Ludlow SP. Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer. Current Problems in Cancer: Case Reports. 2020. doi:10.1016/j.cpccr.2020.100014

BibTeX
@article{Andrews2020,
  author = {Andrews, Stephanie and Ludlow, Steven P.},
  title = {Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer},
  journal = {Current Problems in Cancer: Case Reports},
  year = {2020},
  doi = {10.1016/j.cpccr.2020.100014}
}
Kostenlos starten →